For the Fiscal Year Ended Sept. 30
(Dollars in thousands) |
2002 |
2001 |
|
Revenues |
|
|
Research |
161,851 |
140,768 |
Patient Service, net |
146,890 |
119,182 |
Unrestricted Jimmy Fund Contributions and Bequests |
28,407 |
28,434 |
Other Operating |
26,859 |
27,326 |
Total Revenues |
$364,007 |
$315,710 |
|
Expenses |
|
|
Direct Research |
132,119 |
113,196 |
Direct Patient Care |
108,790 |
95,728 |
Indirect |
121,995 |
109,778 |
Total Operating Expenses |
$362,904 |
$318,702 |
|
Deficit Before Investment Return |
1,103 |
(2,992) |
Realized Investment Return, net |
(34,509) |
(7,363) |
Excess of Revenues Over Expenses |
(33,406) |
(10,355) |
Net Unrealized Investment Gains (Losses) |
10,632 |
(36,967) |
Loss on Early Extinguishment of Debt |
(232) |
— |
Increase (Decrease) in Temporarily Restricted Net Assets |
3,695 |
(8,880) |
(Decrease) Increase in Permanently Restricted Net Assets |
5,760 |
3,162 |
Increase (Decrease) in Net Assets |
(13,551) |
(53,040) |
Net Assets at Beginning of Year |
427,905 |
480,945 |
|
Net Assets at End of Year |
$414,354 |
$427,905 |
|
